Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Compass Diversified
CODI
$924M
| $7.16M | ﹤0.01% |
254,020
+6,316
| +3% | +$173K |
|
2202
Clover Health Investments
CLOV
$2.38B
| $7.15M | ﹤0.01% |
968,002
+435,902
| +82% | +$3.73M |
|
2203
Orthofix Medical
OFIX
$415M
| $7.15M | ﹤0.01% |
187,575
+8,550
| +5% | +$340K |
|
2204
Arcturus Therapeutics
ARCT
$223M
| $7.15M | ﹤0.01% |
149,560
+4,939
| +3% | +$221K |
|
|
AIV
2205
Aimco
AIV
$379M
| $7.14M | ﹤0.01% |
1,042,929
-548,529
| -34% | -$3.78M |
|
|
WOW
2206
DELISTED
WideOpenWest
WOW
| $7.1M | ﹤0.01% |
361,488
+2,326
| +0.6% | +$48.7K |
|
|
TVTY
2207
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $7.1M | ﹤0.01% |
307,710
+33,116
| +12% | +$786K |
|
|
TRTX
2208
TPG RE Finance Trust
TRTX
$616M
| $7.1M | ﹤0.01% |
573,120
+64,455
| +13% | +$825K |
|
2209
Rush Street Interactive
RSI
$2.85B
| $7.06M | ﹤0.01% |
367,602
-29,277
| -7% | -$400K |
|
|
VRAY
2210
DELISTED
ViewRay, Inc.
VRAY
| $7.05M | ﹤0.01% |
977,541
+98,717
| +11% | +$623K |
|
|
AVTA
2211
DELISTED
Avantax, Inc. Common Stock
AVTA
| $7.04M | ﹤0.01% |
451,448
+49,958
| +12% | +$808K |
|
|
GOEV
2212
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $7.02M | ﹤0.01% |
1,985
+134
| +7% | +$478K |
|
|
AD
2213
Array Digital Infrastructure
AD
$3.09B
| $7.01M | ﹤0.01% |
219,852
+19,277
| +10% | +$641K |
|
2214
Kelly Services Class A
KELYA
$566M
| $6.99M | ﹤0.01% |
370,316
+26,058
| +8% | +$546K |
|
|
RNAM
2215
DELISTED
Avidity Biosciences
RNAM
| $6.98M | ﹤0.01% |
283,351
+140,392
| +98% | +$3.05M |
|
2216
Nomad Foods
NOMD
$1.68B
| $6.97M | ﹤0.01% |
252,943
+1,502
| +0.6% | +$40.8K |
|
|
PWSC
2217
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $6.97M | ﹤0.01% |
+283,147
| New | +$7.88M |
|
|
CNR
2218
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $6.96M | ﹤0.01% |
476,016
+59,090
| +14% | +$961K |
|
2219
TFS Financial
TFSL
$4.93B
| $6.95M | ﹤0.01% |
364,593
+9,594
| +3% | +$187K |
|
2220
Liberty Latin America Class A
LILA
$1.67B
| $6.92M | ﹤0.01% |
778,367
-52,895
| -6% | -$488K |
|
2221
Nuvation Bio
NUVB
$2.14B
| $6.91M | ﹤0.01% |
695,418
+317,882
| +84% | +$2.88M |
|
|
CIR
2222
DELISTED
CIRCOR International, Inc
CIR
| $6.89M | ﹤0.01% |
208,718
+7,677
| +4% | +$246K |
|
|
AAN
2223
DELISTED
The Aaron's Company Inc
AAN
| $6.88M | ﹤0.01% |
249,607
-7,279
| -3% | -$205K |
|
2224
Helix Energy Solutions
HLX
$1.49B
| $6.87M | ﹤0.01% |
1,771,333
+68,305
| +4% | +$281K |
|
2225
AngioDynamics
ANGO
$647M
| $6.85M | ﹤0.01% |
263,907
+3,257
| +1% | +$87.1K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.